Selexipag in pulmonary arterial hypertension: a comprehensive review.

被引：0
|
作者：
Dakwa, David S. [1 ]
Mella, Lisa [1 ]
Mella, Natalie [1 ]
Poulakos, Mara N. [1 ]
机构：
[1] Palm Beach Atlantic Univ, W Palm Beach, FL USA
来源：
PHARMACOTHERAPY | 2016年 / 36卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
500
引用
收藏
页码：E301 / E301
页数：1
相关论文
共 50 条
  • [21] Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension
    Grossman, Madeline
    Walker, Stephen
    Ramsey, E. Zachary
    PEDIATRIC CARDIOLOGY, 2024, : 902 - 907
  • [22] Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension
    Granton, John
    Coghlan, Gerry
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [23] Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
    Hardin, Elizabeth Ashley
    Chin, Kelly M.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3747 - 3754
  • [24] Outcomes of selexipag for treatment of pulmonary arterial hypertension in an Asian population
    Loo, Germaine
    Yap, Jonathan
    Hon, Jin Shing
    Ismail, Aidila
    Ruan, Wen
    Low, Andrea
    Lim, Soo Teik
    Tan, Ju Le
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (04) : 219 - 221
  • [25] TRANSITION OF IV TREPROSTINIL TO ORAL SELEXIPAG IN PULMONARY ARTERIAL HYPERTENSION
    Mahoney, Roshan
    Sweidan, Alexander
    Yaghmour, Bassam
    CHEST, 2021, 160 (04) : 2229A - 2229A
  • [26] Early Addition of Selexipag to Double Therapy for Pulmonary Arterial Hypertension
    Burger, Charles D.
    Tang, Wenze
    Tsang, Yuen
    Panjabi, Sumeet
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [27] Pharmacokinetic drug evaluation of selexipag for the treatment of pulmonary arterial hypertension
    Sardana, Mayank
    Moll, Matthew
    Farber, Harrison W.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (12) : 1513 - 1520
  • [28] Pulmonary Hypertension or Pulmonary Arterial Hypertension in Idiopathic Pleuroparenchymal Fibroelastosis: An Updated Comprehensive Review
    Cueto-Robledo, Guillermo
    Guerrero-Velazquez, Jose-Francisco
    Roldan-Valadez, Ernesto
    Graniel-Palafox, Luis-Eugenio
    Cervantes-Naranjo, Frida-Daynette
    Cueto-Romero, Hector-Daniel
    Rivera-Sotelo, Nathaly
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (12)
  • [29] Selexipag for the Treatment of Pediatric Pulmonary Hypertension: A Systematic Review
    Li, Meng
    Liu, Lin
    Liu, Cong
    Chen, Zebin
    Li, Weibin
    Li, Xuejuan
    Ma, Xiaopeng
    Zhang, Yumao
    CLINICAL THERAPEUTICS, 2024, 46 (01) : 59 - 68
  • [30] Clinical pharmacology, efficacy, and safety of selexipag for the treatment of pulmonary arterial hypertension
    Bruderer, Shirin
    Hurst, Noemie
    Remenova, Tatiana
    Dingemanse, Jasper
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 743 - 751
12345